Addiction Treatment — Bodhi Addiction Treatment & Wellness

Families often describe it the same way on the first call: “It’s only tramadol. The doctor prescribed it.” That framing is understandable, and it is also where admissions mistakes start. Tramadol is an opioid with a second, non-opioid mechanism layered on top, and both matter when someone stops taking it. This guide walks through what tramadol dependence looks like in residential treatment, why withdrawal needs medical supervision, and the specific details to have ready before you call admissions.

Tramadol at a glance: the numbers that shape an admission

Tramadol has been a federally controlled Schedule IV substance since August 18, 2014, and its prescribing label caps immediate-release tablets at 400 mg per day. For a person entering residential treatment, the dose actually taken in the last 30 days, counted in milligrams rather than pills, is the single most useful fact the admissions team can receive, because both seizure risk and withdrawal planning scale with it. Tramadol also comes in extended-release forms and in a combination tablet with acetaminophen, and each version changes the medical picture differently.

Many people who become dependent on tramadol did not set out to misuse anything. They started with a legitimate prescription for back pain, a dental procedure or arthritis, and the dose crept up over months. The National Institute on Drug Abuse (NIDA) describes how tolerance and physical dependence can develop with prescription opioids taken as directed, and how that is different from, but can lead to, opioid use disorder. A clinical assessment, not the label on the bottle, decides which one is present.

Why tramadol needs a medical plan, not just willpower

Tramadol behaves differently from most other opioids. In practice, these are the mechanisms that drive the medical decisions during a residential stay:

  • Opioid activity: The liver converts tramadol into a metabolite that acts on opioid receptors, so regular use produces tolerance and opioid-type withdrawal when it stops.
  • Serotonin and norepinephrine effects: Tramadol also slows the reuptake of serotonin and norepinephrine, which is why stopping it can bring mood and anxiety symptoms that look more like antidepressant discontinuation than typical opioid withdrawal.
  • Seizure threshold: The FDA label warns that seizures have been reported with tramadol even within the recommended dose range, and the risk rises at higher doses and when it is combined with certain antidepressants or other medications.
  • Serotonin syndrome risk: Combining tramadol with SSRIs, SNRIs, MAO inhibitors or some migraine medications can cause serotonin syndrome, so the full medication list has to be reviewed before anything is added or changed.
  • Genetic metabolism differences: How fast a person’s liver enzymes convert tramadol varies, which is one reason two people on the same dose can have very different experiences in withdrawal.

Alcohol and benzodiazepines change the risk again. If tramadol is used alongside either one, withdrawal from those substances carries its own seizure risk, and medical supervision is required. Never stop alcohol or benzodiazepines abruptly without a physician’s plan.

What the first week typically looks like

Most people experience a recognizable opioid withdrawal pattern: restlessness, aching muscles and joints, yawning, runny nose, sweating, stomach cramps, diarrhea and poor sleep. Symptoms from immediate-release tramadol commonly begin within a day of the last dose, while extended-release products can shift that timeline later.

A smaller group of people report symptoms that are less typical for opioids: intense anxiety or panic, tingling or numbness in the hands and feet, confusion, and occasionally unusual perceptions. Because these can be frightening and can be mistaken for a new psychiatric problem, it helps when the clinical team knows to expect them. Families visiting during week one often notice that the person seems more anxious than sick, and that is consistent with tramadol’s dual action.

In medically supervised residential care, the plan is individualized. Some people complete a gradual taper. Others are better served by starting a medication for opioid use disorder, such as buprenorphine or methadone, which the American Society of Addiction Medicine (ASAM) national practice guideline supports as effective treatment for opioid use disorder. Comfort medications for sleep, nausea and muscle aches are usually part of the plan, with careful attention to anything that could interact with tramadol’s serotonin effects.

What I see go wrong on admissions calls

From years of placing people in residential treatment, the most common miss with tramadol is not dishonesty. It is under-description. A caller says “a few pills a day,” the intake team hears a modest prescription, and the facility plans for a low-acuity admission. Then it turns out the person was taking far more than prescribed, was also on an antidepressant, and had a seizure once that nobody connected to the medication. Each of those three facts changes the medical plan, and sometimes changes which program is the right fit.

The second inconvenient truth is that tramadol is often the medication a person was switched to because it seemed safer than other opioids. That history means people and families tend to downplay it, and it is one reason we ask about tramadol specifically rather than relying on a general “any opioids?” question.

What to tell admissions: a checklist you can do today

Before you call, take ten minutes and write down the answers to these questions. If you are calling for a loved one, gather what you can and say plainly what you do not know.

  1. Which product: immediate-release, extended-release, or the tramadol and acetaminophen combination tablet. Read the bottle label.
  2. Daily dose in milligrams: count tablets used per day over the last 30 days and multiply by the strength printed on the label. Note the highest single day, not just the average.
  3. Last dose: the date and time of the most recent tablet.
  4. Seizure history: any seizure ever, with or without a known cause, plus any head injury or epilepsy diagnosis.
  5. Every other medication: especially antidepressants, migraine medications, other opioids, sleep medications and benzodiazepines.
  6. Alcohol use: a realistic count of drinks per day. Combined alcohol and tramadol use changes withdrawal safety.
  7. Acetaminophen total: if the combination tablet was used, add up daily acetaminophen from all sources, since high totals raise concerns about liver health.

Then ask the admissions team one direct question: “Who will supervise the taper or medication start, and how often will vital signs be checked in the first 72 hours?” A clear answer is a good sign. You can reach our team at (877) 328-1968 to walk through this list together, and you can also verify insurance benefits before the call so cost questions do not delay a safe start.

How residential treatment builds on detox

Withdrawal management is the beginning, not the treatment itself. In residential treatment, the work shifts to the reasons the dose climbed: untreated pain, sleep problems, anxiety, depression, or stress that the medication was quietly managing. A good program coordinates with a pain specialist where needed, so that leaving tramadol does not mean leaving pain untreated. Non-opioid pain approaches, physical therapy and behavioral therapies are typically part of that plan.

Discharge planning should include whether to continue a medication for opioid use disorder, naloxone for the home, and a follow-up appointment with a prescriber who knows the full history. The SAMHSA National Helpline at 1-800-662-4357 offers free, confidential referral information around the clock, and the CDC overdose prevention resources explain how lost tolerance after a period of abstinence raises overdose risk if use resumes.

Safety first

If someone taking tramadol has a seizure, becomes very confused, has a high fever with muscle rigidity or twitching, or has slow or shallow breathing, call 911. Naloxone can reverse opioid effects and should be given if an overdose is suspected, but it is not a seizure treatment, so emergency care is still needed. If you or someone you love is in emotional crisis, call or text 988.

If tramadol has become harder to stop than expected, you do not have to sort out the medical plan alone. Call (877) 328-1968 and we will help you understand the options, the level of care that fits, and what to bring on admission day. You can read more about our clinical background on Jonathan Beazley’s profile.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed physician or addiction specialist. Do not stop or change any prescribed medication, including tramadol, alcohol or benzodiazepines, without medical supervision.

Bodhi Addiction — Bodhi Addiction Treatment & Wellness

Most people who reach out to us about zolpidem (sold as Ambien and Ambien CR) did not set out to misuse anything. A doctor prescribed a sleep medication, it worked, and over months or years one tablet became two, then a second dose at 3 a.m., then a glass of wine to help it along. By the time a spouse or adult child calls, the question is rarely “is this a problem?” It is “how do we stop safely, and what does admission actually involve?” This guide answers the second question.

Zolpidem and Residential Treatment: The Key Facts

Zolpidem is a Schedule IV prescription sleep medication that acts on the same GABA-A receptor system as benzodiazepines and alcohol. In April 2019 the U.S. Food and Drug Administration added a boxed warning, its strongest safety label, to zolpidem, zaleplon and eszopiclone after reports of serious injuries and deaths linked to complex sleep behaviors such as sleepwalking and sleep-driving. Because zolpidem dependence develops through the same brain system as alcohol and benzodiazepine dependence, a person who has been taking more than prescribed, taking it during the day, or combining it with alcohol should not stop abruptly on their own. The safer route is a medically supervised taper, which a residential program with medical staff can provide.

A second date matters for families. In January 2013 the FDA lowered the recommended starting dose of immediate-release zolpidem for women from 10 mg to 5 mg (and of extended-release from 12.5 mg to 6.25 mg) because blood levels high enough to impair driving were found the next morning. If someone has been taking several times that amount nightly, next-morning impairment is a safety issue now, not only a treatment issue later.

What Zolpidem Dependence Looks Like Before Admission

From the admissions side, the picture is consistent. People describe lying awake for an hour or more if they skip a dose, then taking extra “just to get some sleep.” Families describe conversations the person does not remember the next day, late-night online orders, food eaten with no memory of it, or a car moved in the night. Some people start taking a half tablet in the afternoon because it takes the edge off anxiety. Prescriptions run out before the refill date, and a second prescriber, or a supply from a friend, fills the gap.

None of this means a person is weak or careless. Sedative-hypnotic use disorder is a recognized medical condition, and the National Institute on Drug Abuse (NIDA) lists prescription sedatives among the medications that can lead to dependence and addiction when they are misused.

Why Use Escalates: The Five Mechanisms We See

  • Tolerance: The same dose produces less sleep over weeks to months, so the dose creeps up to get the original effect.
  • Rebound insomnia: Skipping a night produces worse sleep than before the medication was started, which convinces the person they cannot sleep without it.
  • Daytime use: Zolpidem’s calming effect gets used for anxiety or stress during the day, which turns a sleep aid into an all-day sedative.
  • Alcohol stacking: Alcohol and zolpidem both depress breathing and coordination, and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) flags sleep medications among the dangerous alcohol-medication combinations.
  • Amnesia hides the amount: Because zolpidem can cause memory gaps, the person may sincerely not know how many tablets they took on a given night.

Why Zolpidem Is Not Stopped Cold

When the brain has adapted to a GABA-A medication, removing it suddenly can produce rebound insomnia, anxiety, agitation, tremor and, particularly after high doses, seizures. The risk depends on the dose, how long it has been taken, and what else is in the picture. Alcohol and benzodiazepines matter most here: alcohol and benzodiazepine withdrawal carry seizure risk, and anyone dependent on either, alone or alongside zolpidem, requires medical supervision to stop. The same caution applies to stopping a high daily dose of zolpidem itself.

A taper is planned by a prescriber based on the actual dose being taken, not the dose on the label. In some cases the medical team converts to a longer-acting medication and reduces that gradually; in others zolpidem itself is reduced step by step. The schedule is individual, and it is adjusted if symptoms appear. If you are reading this before admission, do not stop or sharply cut your dose on your own. Keep taking it as you have been, unless your prescriber has given you different instructions, and tell admissions exactly when you took the last dose.

What Happens in Week One of Residential Treatment

The first days are about safety and sleep, in that order. Expect a medical and psychiatric assessment on arrival, a review of every bottle you bring, and regular vital-sign and symptom checks while the taper begins. The first several nights are usually the hardest; many people sleep in short stretches and wake early. That is expected, and staff are awake overnight.

Programs place people by clinical need using frameworks such as the American Society of Addiction Medicine (ASAM) clinical guidelines, so the level of medical monitoring during a sedative taper is matched to the risk. You can read more about how our residential treatment program structures the first week and the medical support around it.

Beyond the taper, week one also starts the work that keeps the change from reversing: screening for depression, anxiety and trauma that the medication may have been covering, and counseling that looks at what the nightly ritual was doing for the person.

What to Tell Admissions: A 10-Minute Checklist

In my years doing intake calls and interventions, the most common gap I hear is the difference between the dose on the bottle and the dose actually being taken. Admissions can only plan a safe taper around the real number. Before you call (877) 328-1968, take ten minutes and write down the following:

  1. The prescribed dose and the name of every prescriber, including telehealth and urgent care.
  2. The dose actually taken on a typical night over the last two weeks, including middle-of-the-night doses and any daytime use.
  3. The last fill date and quantity from the label. Count what is left. Fill date, quantity and remaining count together show the true daily rate better than memory does.
  4. Every other sedative: alcohol (in standard drinks), benzodiazepines, gabapentin or pregabalin, opioids, muscle relaxants, cannabis and over-the-counter sleep aids.
  5. Any seizure history, any withdrawal you have had before, and any falls, sleep-driving or blackout events.
  6. The time of your last dose, written down on admission day.

Bring all medication bottles, in their original labeled containers, on admission day. If you are not sure what your plan will cover, our team can verify your insurance benefits before you commit to a date.

Treating the Insomnia Underneath

Stopping zolpidem does not end the sleep problem it was prescribed for, and pretending otherwise sets people up to restart. Sleep usually improves gradually over the weeks after a taper. During treatment, care focuses on approaches that do not depend on a sedative: consistent wake times, daylight and movement, limiting caffeine, and cognitive behavioral therapy for insomnia (CBT-I), a structured, non-drug treatment. Anxiety, depression and trauma symptoms that were being quieted at night are treated directly, and the discharge plan should name who will manage sleep afterward.

Getting Started

If you or someone you love depends on zolpidem, the next step is a conversation, not a decision to stop tonight. Call (877) 328-1968 to talk through the dose, the timeline and what admission involves. For free, confidential treatment referral 24 hours a day, you can also reach SAMHSA’s National Helpline at 1-800-662-4357. If someone is hard to wake, breathing slowly, or has had a seizure, call 911. If you are in emotional crisis, call or text 988.

Written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, drawing on his work in admissions, intervention and residential addiction treatment in Northern California.

Educational disclaimer: This article is for general educational purposes only and is not medical advice. It does not replace an evaluation by a licensed medical professional. Do not stop, reduce or change any prescribed medication without guidance from your prescriber. Withdrawal from sedatives, alcohol or benzodiazepines can be dangerous and requires medical supervision. If you are experiencing a medical emergency, call 911.

Drug and Alcohol Rehab Treatment Serving Kirkland

Gabapentin (brand name Neurontin) and pregabalin (Lyrica) are prescribed every day for nerve pain, seizures, and sometimes off-label for anxiety, sleep, or alcohol withdrawal. Because they arrive from a pharmacy with a doctor’s name on the label, many people don’t think of them as part of their substance use at all. In residential admissions, that is exactly why they get missed. This guide covers how these medications are handled when someone enters residential treatment, why stopping them suddenly is not safe, and what to have ready before you call admissions.

The Short Answer: Gabapentin Should Not Be Stopped Abruptly

Gabapentin should never be stopped “cold turkey” on admission to residential treatment. The FDA-approved prescribing information for Neurontin directs that when the medication is reduced or discontinued, it be done gradually over a minimum of one week, and it warns that antiepileptic drugs should not be stopped abruptly because of the possibility of increased seizure frequency. People who have been taking more than prescribed, or combining gabapentin with alcohol, benzodiazepines, or opioids, generally need a slower, medically supervised taper than that one-week floor, planned by a prescriber who knows their full history.

Why Gabapentin and Pregabalin Misuse Is Often Missed

From the admissions side, the pattern is consistent: a person describes their alcohol or opioid use in detail, then mentions gabapentin almost as an afterthought, or not at all. Several things drive that:

  • It is prescribed, not purchased: A pharmacy label makes the medication feel like healthcare rather than substance use, even when the daily amount has drifted well past the prescription.
  • Gabapentin is not federally controlled: Pregabalin is a Schedule V controlled substance under federal law, but gabapentin is not federally scheduled, so it can fall outside the questions people expect to be asked.
  • It is used to manage other substances: Some people use gabapentin to soften opioid withdrawal or to blunt alcohol cravings, so they see it as part of the solution rather than part of the problem.
  • It amplifies other depressants: Taken with opioids or alcohol, gabapentin can intensify sedation, which is part of why some people take extra and part of why the combination is dangerous.

None of this means a gabapentin prescription is a problem in itself. Many people take it exactly as directed and benefit. The clinical question in admissions is simply whether the amount, the source, and the combination with other substances match the prescription.

The Breathing Risk When Gabapentinoids Are Combined With Opioids

In December 2019, the U.S. Food and Drug Administration added warnings that gabapentin and pregabalin can cause serious breathing difficulties in people with respiratory risk factors, including people who also use opioids or other central nervous system depressants, older adults, and people with lung conditions such as COPD. This matters for residential admissions because many people entering treatment for opioid use disorder are also taking gabapentin, prescribed or not.

The Centers for Disease Control and Prevention (CDC) describes how combining opioids with other sedating substances raises overdose risk. A complete medication list lets the medical team plan withdrawal care and make sure naloxone is part of the safety plan. If you are worried about someone right now, and they are hard to wake, breathing slowly, or making snoring or gurgling sounds, call 911.

What Withdrawal Can Look Like in the First Week

People who have been taking high daily amounts and stop suddenly may report anxiety, agitation, restlessness, insomnia, sweating, nausea, and a rebound of the pain the medication was treating. Seizures are the most serious risk, especially for anyone with a seizure history or who is also coming off alcohol or benzodiazepines.

That last point is critical. Alcohol withdrawal and benzodiazepine withdrawal both carry a risk of seizures and can be life-threatening. Medical supervision is required. When gabapentin or pregabalin dependence overlaps with either of those, withdrawal planning needs to account for all of them at once. Families sometimes notice the first week as a person who seems “on edge” and unable to sleep, and that is a reason to keep the medical team informed, not a reason to give an extra dose from the home supply.

The National Institute on Drug Abuse (NIDA) notes that medically managed withdrawal is only the first stage of treatment and is rarely enough on its own to sustain recovery. The taper is the start, not the treatment.

What to Tell Admissions: A Checklist to Fill In Today

Before you call, take five minutes and write down the following. If you are calling for a family member, gather what you can and leave the rest blank. Admissions can work with partial information, but not with information nobody mentions.

  1. Exact product and strength: Gabapentin or pregabalin, the milligram strength printed on the bottle, and whether it is capsules, tablets, or liquid.
  2. Prescribed amount versus actual amount: What the label says per day, and what is actually being taken per day. Count what is left in the bottle against the fill date if you are unsure.
  3. Source: One prescriber, more than one prescriber, or obtained from someone else. This is clinical information, not a judgment.
  4. Time of the last dose: Withdrawal planning depends on it.
  5. Everything else taken alongside it: Opioids, buprenorphine or methadone, benzodiazepines, alcohol, sleep medications, or muscle relaxants.
  6. Seizure history: Any past seizure, including during a previous withdrawal.
  7. Why it was first prescribed: Nerve pain, seizures, anxiety, or sleep. The underlying condition still needs a treatment plan after the taper.

Bring the original pharmacy bottles on admission day. Our admissions team can walk you through what to bring and how prescriptions are reconciled when you call (877) 328-1968.

How Residential Treatment Handles the Taper

In a residential setting, gabapentin or pregabalin is typically reviewed by the medical team during intake. The prescriber confirms the actual daily amount, considers other substances and health conditions, and sets a taper schedule. Doses are held and dispensed by staff rather than self-administered, which removes the guesswork and the temptation to take extra on a hard night.

Because the taper usually runs alongside therapy rather than before it, people can begin residential treatment work in the first days instead of waiting for withdrawal to finish. If pain was the original reason for the prescription, the plan should include non-addictive pain strategies and a handoff to an outpatient prescriber at discharge. The Substance Abuse and Mental Health Services Administration (SAMHSA) emphasizes treating co-occurring physical and mental health conditions alongside substance use, and chronic pain is one of the most common examples.

A residential stay is not the right level of care for everyone who takes gabapentin. Someone taking it exactly as prescribed, with no other substance use, may simply need their own prescriber to manage a taper. Residential care makes sense when the medication is part of a broader pattern, when other depressants are involved, or when previous attempts to cut back on their own have not held.

Questions to Ask Before You Commit to a Program

  • Does the program have a prescriber on staff who reviews gabapentin and pregabalin at intake, rather than stopping all non-essential medications?
  • How is a taper handled when alcohol, benzodiazepines, or opioids are also involved?
  • Is naloxone included in the discharge plan for anyone with opioid use?
  • What happens to the original pain or anxiety condition after the taper ends?
  • Will my insurance cover the stay? You can start that process through our insurance verification page.

A Note From the Clinical Side

The most useful thing a person or family can do is mention gabapentin or pregabalin on the very first call, even if it seems minor. Medication that is disclosed can be tapered safely. Medication that surfaces on day three, after a withdrawal symptom nobody planned for, is harder for everyone. If you are not sure whether it matters, assume it does and say it out loud.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. To talk through a specific situation confidentially, call (877) 328-1968.

This article is for educational purposes only and is not medical advice. Do not stop, reduce, or change any prescribed medication without guidance from your prescriber. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.

Residential Treatment | Bodhi Addiction & Wellness

Most families calling about alcohol detox ask about seizures and the shakes, and they should. Fewer ask about a vitamin. Yet thiamine, also called vitamin B1, is one of the first things a medical team thinks about when someone who has been drinking heavily comes in for withdrawal care. This guide explains why, what the warning signs look like, and what to tell admissions so the team can plan for it from the first hour.

The Short Version: Three Signs and One Rule

Wernicke encephalopathy is a brain emergency caused by a shortage of thiamine (vitamin B1), and in people who drink heavily it is classically described by three signs: confusion, an unsteady walk, and abnormal eye movements. Because many people show only one or two of the three, clinicians are taught to give thiamine whenever the risk is present rather than waiting for all three, and to give it before or alongside any glucose, since sugar given to a thiamine-depleted brain can make the condition worse.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) Core Resource on Alcohol describes thiamine deficiency and Wernicke-Korsakoff syndrome as recognized consequences of heavy, long-term drinking. If Wernicke encephalopathy is not treated promptly, it can progress to Korsakoff syndrome, a lasting problem with memory and learning that may not fully recover. That is why it is treated as a time-sensitive part of withdrawal care rather than a nutrition footnote.

Why Heavy Drinking Drains Thiamine

The body cannot make thiamine and holds only a limited supply, so it depends on a steady intake from food. Heavy drinking undercuts that supply from several directions at once:

  • Low intake: When alcohol replaces meals for days or weeks, very little thiamine comes in through food.
  • Poor absorption: Alcohol interferes with how the gut absorbs thiamine, so even the food that is eaten delivers less.
  • Reduced storage and use: Liver damage and alcohol’s effects on cells reduce how well the body stores thiamine and puts it to work.
  • Vomiting and diarrhea: Repeated stomach illness during heavy drinking or early withdrawal pushes intake down further.
  • Prior weight-loss surgery: Bariatric procedures change absorption and add to the risk when combined with heavy drinking.

None of these factors announces itself. A person can look well nourished and still be low on thiamine, which is one reason clinicians do not rely on appearance.

What Families Actually Notice

From the intervention and admissions side, the description we hear most often is some version of “they seemed drunk, but they swore they had not had anything.” A person who is newly confused, unusually slow to answer simple questions, or walking with a wide, careful, unsteady gait in the days after cutting back is a person who needs a medical evaluation the same day, not a wait-and-see weekend. Families sometimes also notice that the person’s eyes flicker or that they complain of double vision.

These signs overlap with intoxication, with alcohol withdrawal, with low blood sugar, and with a head injury from a fall. Sorting them out is a clinician’s job. The family’s job is to report what they saw, when it started, and how much the person has been eating. If someone is very confused, cannot stay awake, is having a seizure, or cannot walk safely, call 911.

Thiamine Before Glucose: Why the Order Matters

The brain uses thiamine to process glucose for energy. When someone who is already low on thiamine receives a large dose of sugar, such as intravenous fluids containing dextrose, the brain’s demand for thiamine rises suddenly and can tip a borderline deficiency into Wernicke encephalopathy. For that reason, standard medical practice is to give thiamine before or together with glucose in anyone at risk.

This has practical consequences. Many people arrive for residential care by way of an emergency room, where IV fluids are common. Others are started on a meal plan after days of eating almost nothing. In both situations the medical team wants to know early whether thiamine has already been given, by which route, and when. Because absorption from the gut is unreliable in people who have been drinking heavily, clinicians often give thiamine by injection or IV at first, then move to tablets once the person is eating and stable.

The American Society of Addiction Medicine (ASAM) clinical guidelines on alcohol withdrawal management address thiamine as part of supportive care alongside withdrawal medication, monitoring, and nutrition. Exact dosing is set by the prescribing clinician for each person.

Withdrawal Safety Comes First

Thiamine is one piece of a larger picture. Alcohol withdrawal can cause seizures and delirium tremens, and it can be life-threatening. Stopping heavy alcohol use, or stopping benzodiazepines, requires medical supervision. Do not try to detox at home by stopping suddenly, even with vitamins on hand. A bottle of over-the-counter B vitamins does not replace a medical assessment, withdrawal medication, or monitoring.

In residential treatment, withdrawal care, nutrition, and medical monitoring happen together, so thiamine is part of the admission plan rather than something added after a problem appears.

What to Tell Admissions: A Checklist You Can Fill Out Today

Before the admissions call, take ten minutes and write down answers to these questions. They help the medical team judge thiamine risk and plan the first day:

  1. Eating: Over the past two weeks, on how many days did the person eat at least one real meal?
  2. Vomiting: Has there been repeated vomiting or diarrhea, and for how many days?
  3. Weight: Has there been noticeable weight loss in recent months?
  4. Surgery: Has the person ever had bariatric or other stomach surgery?
  5. Recent care: Was there an ER visit or hospital stay in the last week? Was thiamine given, and were IV fluids given? Ask the hospital for the discharge summary and medication list.
  6. New symptoms: Any new confusion, unsteady walking, falls, or vision changes, and on what date did they start?
  7. Last drink and amount: When was the last drink, and roughly how much has been typical per day?

Then ask two direct questions on the call: “How is thiamine handled at admission for someone with this history?” and “If IV fluids are needed, will thiamine be given first?” A program that provides medically managed withdrawal care should be able to answer both clearly. You can reach our admissions team at (877) 328-1968.

Cost and Coverage Questions

Families often worry that medical extras will add surprise charges. Thiamine itself is an inexpensive, routine medication, and it is generally bundled into withdrawal and residential care rather than billed as a separate line. Coverage for the overall level of care is the bigger question. You can verify your insurance before admission, and it helps to ask whether medically monitored withdrawal is covered as part of the residential stay.

If you are not ready for residential care, or are unsure what level of care fits, the SAMHSA National Helpline offers free, confidential treatment referral 24 hours a day, 365 days a year at 1-800-662-4357.

After Detox: Why Thiamine Continues

Replenishing thiamine is not a one-day event. Many people stay on oral thiamine, often alongside other vitamins, for a period after withdrawal while eating patterns recover. If memory or balance problems linger after the first week or two, that is worth raising directly with the medical team, since some effects of deficiency improve slowly and some need further evaluation. Ask before discharge whether thiamine should continue at home, for how long, and who will follow up.

Our addiction treatment team in Northern California works with families on these questions from the first call through discharge planning. To talk through a specific situation, call (877) 328-1968.

Educational Disclaimer

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Thiamine dosing and route should be decided by a licensed clinician. Alcohol and benzodiazepine withdrawal can cause seizures and can be life-threatening; seek medical supervision before stopping. If you or someone else is in immediate danger, call 911. For a mental health or suicide crisis, call or text 988.

how to tell your employer you're going to residential addiction treatment private conversation

If Medi-Cal is your only coverage, or the only coverage of someone you love, the route into residential addiction treatment in California looks different from the one most treatment websites describe. The calls that go nowhere usually go nowhere for one reason: the family is calling the wrong door. This guide lays out how Medi-Cal actually pays for residential care, who you call first, and what to have in hand before you dial.

How Medi-Cal Pays for Residential Treatment

In California, Medi-Cal pays for residential addiction treatment through county behavioral health systems, not through the health plan named on most members’ cards. Adults ages 19 to 64 generally qualify for Medi-Cal with household income up to 138 percent of the federal poverty level, and in counties that take part in the Drug Medi-Cal Organized Delivery System (DMC-ODS), residential treatment is a covered benefit. The entry point is the county’s substance use disorder access line, which arranges an assessment based on the ASAM Criteria and then refers to a county-contracted residential program.

That paragraph is the whole map. Medi-Cal is California’s Medicaid program. It is not Medicare, which is the federal program mostly for people 65 and older, and mixing the two up on the first call costs time. Most Medi-Cal members are enrolled in a managed care health plan for doctor visits and prescriptions, but specialty substance use treatment, including residential care, is generally handled by the county where the member lives. Coverage details, the list of contracted programs, and wait times differ from county to county, and federal Medicaid rules are changing in 2026 and 2027, so confirm current eligibility with your county rather than relying on any single article, including this one.

Why Calls to Private Programs Stall

In consultation calls, a pattern we hear again and again is a family that has spent a week phoning private residential programs from a search engine, each one asking for insurance information and then going quiet. The reasons are structural, not personal:

  • Certification gap: A program has to be Drug Medi-Cal certified and contracted with a county to bill Medi-Cal, and many private residential programs are neither.
  • The 16-bed rule: Federal Medicaid has long barred payment for adults ages 21 to 64 in an “institution for mental diseases” with more than 16 beds, and California’s DMC-ODS operates under federal waiver authority that allows residential substance use care in larger facilities only through the county system.
  • County of residence: Medi-Cal is tied to the county where the member lives, so a program in a neighboring county may not be reachable without a referral or a county-to-county arrangement.
  • Payer of last resort: When someone has both private insurance and Medi-Cal, the private plan pays first, so the private plan’s rules, network, and authorization process come into play before Medi-Cal does.

None of this means Medi-Cal members cannot get residential care. It means the door is the county, and calling it first usually saves days.

What to Do Today, Before You Call

Gather four things before you pick up the phone. This takes about ten minutes and makes the call far more productive.

  1. The Medi-Cal card or benefits identification number. If the card is lost, the county social services office can confirm active coverage.
  2. The county of residence. This is the county where the person lives and receives mail, not the county where a preferred program sits.
  3. A plain list of what is being used, how much, and when the last use was. Include alcohol, prescription medications, and anything bought on the street. Admissions and assessment staff need this to judge withdrawal risk safely, so accuracy matters more than tidiness.
  4. A current medication list, including doses and the prescribing doctor’s name.

Then find the county’s substance use disorder access line. It is usually posted on the county behavioral health department’s website, and many counties list it on the back of member materials. California’s approach is meant to be “no wrong door,” so if you reach the managed care plan first, ask them directly for the county substance use access line number. If you cannot find a county number, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and open 24 hours a day, and can point you toward local options.

Four Questions to Ask the County Access Line

Write these down and ask them in this order:

  1. “Does this county participate in the Drug Medi-Cal Organized Delivery System, and is residential treatment covered here?”
  2. “How is the assessment done, by phone or in person, and how soon can it happen?”
  3. “If the assessment recommends residential care and no bed is open, what interim services are available while we wait?”
  4. “Is withdrawal management, meaning medically supervised detox, arranged separately or as part of the residential referral?”

The fourth question matters more than it sounds. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening, and stopping either one abruptly at home is not safe. Medical supervision is required. If the person drinks heavily every day or takes benzodiazepines such as alprazolam, clonazepam, or lorazepam daily, say so clearly on the first call so the county can route to a setting with medical staff. If someone is in withdrawal right now and is confused, shaking severely, hallucinating, or has had a seizure, call 911. If someone is in emotional crisis or thinking about suicide, call or text 988.

What the Assessment Covers and What Comes Next

The county assessment uses the ASAM Criteria, a framework published by the American Society of Addiction Medicine that looks at withdrawal risk, physical health, mental health, readiness for change, relapse risk, and the home environment. The goal is to match the person to the least restrictive level of care that is still safe, which may be residential, an intensive outpatient program, or outpatient services with medication. The National Institute on Drug Abuse describes this kind of individualized matching as a core principle of effective treatment, and notes that staying in treatment long enough matters.

Families often expect a yes or no on the first call. More often, the first call produces an appointment, the assessment produces a recommendation, and the recommendation produces a referral to a specific program. Some counties move through this in days; others have waits. If there is a wait, ask about outpatient services and medication for opioid or alcohol use disorder in the meantime. Those can start sooner and are not a lesser choice.

If you also have private insurance, or are weighing whether a private plan through work or Covered California would open more options, the residential treatment overview and our insurance verification page explain what a benefits check can and cannot tell you.

Where Bodhi Fits

Bodhi is a treatment consulting and referral service based in Capitola. When Medi-Cal is the only coverage, the honest answer is often that the county system is the right path, and we will tell you that rather than send you through a list of programs that cannot bill Medi-Cal. When there is other coverage, or the situation is complicated by a co-occurring mental health condition, a pending court date, or a recent hospital stay, a consultation can help sort out which route fits. You can reach us at (877) 328-1968.

The single most useful thing you can do today is find your county’s substance use access line and write down the four questions above. If you want help reading what the county tells you, or if the county route stalls, call (877) 328-1968 and we will walk through it with you.

This article is for educational purposes only and is not medical, legal, or insurance advice. Medi-Cal eligibility rules, county benefits, and federal Medicaid requirements change; confirm current details with your county behavioral health department or Medi-Cal office. Do not stop alcohol or benzodiazepines suddenly without medical supervision. If you or someone you love is in immediate danger, call 911. For mental health crisis support, call or text 988.

Crop 0 0 1200 628 0 Featuredimage3 — Bodhi Addiction Treatment & Wellness

GHB, and the closely related products GBL and 1,4-butanediol, get less attention than fentanyl or methamphetamine, but for the people who become dependent on them the withdrawal is one of the most time-sensitive situations an admissions team handles. This guide explains, in procedural terms, how residential treatment approaches GHB-type dependence, why timing matters more than almost anything else, and exactly what to have ready when you call admissions.

Why GHB Withdrawal Is Handled as a Medical Priority

GHB (gamma-hydroxybutyrate) is a central nervous system depressant. GBL (gamma-butyrolactone) and 1,4-butanediol are sold as solvents or cleaning products and are converted into GHB inside the body, so clinically they are treated as the same problem. Federally, GHB was placed in Schedule I in March 2000, while the prescription form, sodium oxybate, is a Schedule III medication used for narcolepsy. The legal category matters less to an admissions team than the pharmacology: these substances act quickly and leave the body quickly.

GHB, GBL and 1,4-butanediol withdrawal can begin within roughly one to six hours of the last dose, because the drugs are cleared from the body so fast; people who are physically dependent often dose every one to three hours around the clock, including through the night. Withdrawal can progress from anxiety, tremor and insomnia to agitation, hallucinations, delirium and seizures, so stopping these substances requires medical supervision, and a residential program will ask for the exact dosing interval and the time of the last dose before it agrees on where and how admission happens.

That paragraph is the single most important thing in this article. Like alcohol and benzodiazepine withdrawal, GHB-type withdrawal carries a real risk of seizures and delirium. It should never be attempted alone at home, and “tapering yourself down” without a prescriber is not a safe plan.

What We Actually See on Admissions Calls

From the admissions and intervention side of this work, the pattern on GHB calls is consistent. The person calling is often a partner or friend, not the person using. They describe someone who sets alarms at night to dose, who carries a small bottle or a water bottle with a measured amount in it, and who becomes shaky, sweaty and frightened within a few hours of missing a dose. Families frequently describe it as “anxiety” or “not sleeping” before they connect it to the bottle.

The detail that most often goes unreported is the dosing interval. People will tell us how much they use per day, but not how many hours they can go between doses. For GHB, the interval is the number that tells a clinician how dependent the body is and how quickly withdrawal will start. A person who is dosing every 90 minutes is in a very different medical situation from someone who uses on weekends.

The second inconvenient truth: GHB is not on a standard urine drug panel. A routine test will usually come back negative, and the substance is typically detectable in urine for only about 12 hours. That means the clinical team depends on what you tell them. Honest, specific information is what keeps the admission safe.

What Drives the Risk: Labelled Causes

  • Short half-life: GHB is eliminated within hours, so withdrawal arrives fast and can escalate the same day the last dose was taken.
  • Round-the-clock dosing: Dosing every one to three hours keeps the brain continuously adapted to the drug, which increases the severity of withdrawal when it stops.
  • Hidden product switching: Many people move from GHB to GBL or 1,4-butanediol because they are easier to buy, and the dose equivalence between products is unpredictable.
  • Alcohol and sedative combinations: Mixing GHB with alcohol, benzodiazepines or opioids raises overdose risk and complicates withdrawal planning.
  • No test confirmation: Because standard panels miss GHB, an under-reported history can lead to an under-planned withdrawal.

How the Admissions Process Works for GHB-Type Dependence

When you call, the admissions team is trying to answer one question first: is this person safe to admit directly to residential care, or do they need hospital-level medically managed withdrawal before residential treatment begins? The ASAM Criteria, the framework most programs and insurers use to match people to a level of care, treat withdrawal risk as its own dimension of assessment for exactly this reason.

In practice the steps look like this:

  1. Screening call: substance or substances, amount per dose, interval between doses, time of last dose, any past withdrawal seizures or delirium, and other substances used.
  2. Medical review: a clinician reviews the history and decides whether withdrawal can be managed in a medically monitored setting or whether a hospital detox comes first.
  3. Insurance verification: benefits are checked so the family knows what is covered before travel. You can start that step through our insurance verification page.
  4. Arrival timing: because withdrawal starts within hours, travel is planned so the person is not stranded between their last dose and medical care.
  5. Transition into residential care: once withdrawal is stable, the person moves into the full residential treatment program, where the longer work on dependence, sleep, anxiety and relapse prevention begins.

If you are unsure whether residential care is the right level, a free consultation can walk through the options before anyone commits. You can also call us directly at (877) 328-1968.

What to Do Today: A Checklist for the Admissions Call

Before you call, write down the following on a single sheet of paper or in a phone note. This takes about ten minutes and it is the most useful thing a family can bring to the first conversation.

  • Which product: GHB, GBL, 1,4-butanediol, or more than one. If you do not know, say so.
  • The usual dose and how it is measured (capful, syringe, milliliters).
  • The longest time the person has gone between doses in the past week, and what happened when they did.
  • The exact time of the most recent dose.
  • Any history of seizures, hallucinations, confusion or a hospital visit during withdrawal.
  • Alcohol, benzodiazepines, opioids, stimulants or prescription medications also being taken.
  • Insurance card details and a list of current prescriptions.

Then ask admissions one direct question: “Based on this dosing interval, will withdrawal be managed on site, or do you need a hospital to handle the first phase?” A clear answer to that question tells you the program has thought about GHB specifically.

Safety in the Meantime

Do not stop GHB, GBL or 1,4-butanediol abruptly without medical support, and do not substitute alcohol or someone else’s benzodiazepines to get through withdrawal. Both can cause dangerous sedation, and alcohol and benzodiazepine withdrawal also carry seizure risk that requires medical supervision.

Call 911 or go to an emergency department if someone has a seizure, cannot be woken, is breathing slowly, is severely confused or is seeing or hearing things that are not there. GHB overdose can cause sudden unconsciousness, and the combination with alcohol is especially risky. If there is any chance opioids are involved, give naloxone if it is available while waiting for help.

For help finding care any time of day, the SAMHSA National Helpline is free and confidential at 1-800-662-4357. If someone is in emotional crisis or thinking about suicide, call or text 988.

What Residential Treatment Adds After Withdrawal

Getting through withdrawal is the start, not the treatment. People who have dosed around the clock often have weeks of disrupted sleep, rebound anxiety and strong cravings tied to the nighttime routine. Residential care gives structure to those weeks: individual and group therapy, treatment of co-occurring anxiety, depression or trauma, and a plan for the sleep problems that frequently drove GHB use in the first place. The National Institute on Drug Abuse describes GHB among the depressants with risks of dependence and overdose, and it frames substance use disorders as treatable conditions that respond to sustained care.

Recovery from GHB-type dependence is possible. It goes most smoothly when the first phone call contains accurate, specific information and the program has a clear medical plan for the first 24 to 72 hours.

If you are preparing for that call now, our admissions team is available at (877) 328-1968.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a qualified healthcare provider. GHB, GBL and 1,4-butanediol withdrawal can be life-threatening and requires medical supervision. If you or someone you love is in immediate danger, call 911.

Crop 0 0 1200 628 0 Featuredimage2 — Bodhi Addiction Treatment & Wellness

Ketamine rarely comes up first on an admissions call. People mention alcohol, pills, or stimulants, and ketamine surfaces ten minutes in, usually described as “not really the problem” or “something my doctor started.” This guide covers what residential treatment actually does when ketamine is part of the picture: how use is assessed, why there is no detox medication for it, what happens to the bladder, how a legitimate ketamine prescription is handled, and exactly what to tell admissions so the first week is planned correctly. If you want to talk it through now, call (877) 328-1968.

The Short Version: How Ketamine Is Classified and Treated

Ketamine is a Schedule III controlled substance under federal law, approved as an anesthetic, and there is no FDA-approved medication for treating ketamine use disorder. Esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, can only be given in a certified healthcare setting, where the patient is monitored for at least two hours after each dose and cannot take the medication home. So when someone has ketamine at home in powder, liquid, or lozenge form, it is either illicit, diverted, or prescribed off-label by a telehealth or clinic prescriber, and residential treatment for problematic ketamine use relies on medical monitoring, symptom management, and behavioral therapy rather than a replacement medication.

How Admissions Decides Whether Ketamine Use Is a Disorder

In the DSM-5, ketamine falls under the phencyclidine-type substances. A use disorder is diagnosed when at least two of the listed criteria occur within a 12-month period: using more than intended, failed attempts to cut down, cravings, giving up activities, continued use despite physical or psychological harm, tolerance, and so on. One difference matters for planning: unlike alcohol or opioids, the criteria list does not include a defined withdrawal syndrome. That does not mean stopping is easy. It means the difficult part is usually psychological rather than a predictable physical withdrawal curve.

A clinician will also use the ASAM Criteria to decide whether residential treatment is the right level of care, looking at medical risk, mental health, readiness, and how safe the home environment is.

Why Ketamine Use Escalates

From the admissions side, these are the patterns that come up again and again. They are clinical observations, not a checklist for self-diagnosis.

  • Fast tolerance: The dissociative effect fades with repeated use, so people take larger amounts or use more often to get the same distance from their thoughts.
  • Dissociation as relief: For someone with depression, anxiety, or trauma, the detached state can feel like the first break in months, which makes it hard to see the use as a problem.
  • The prescription bridge: Some people start with ketamine for depression and begin taking extra doses between sessions or buying more when the supply runs out.
  • Short effect, repeated dosing: The effects wear off relatively quickly, which encourages several doses in a single night.
  • Mixing with depressants: Ketamine is often combined with alcohol or benzodiazepines, which raises the risk of dangerous sedation and slowed breathing.

What the First Week Actually Looks Like

Because there is no standard ketamine detox protocol, the first days in residential care are about watching closely and treating what shows up. People commonly describe low mood, poor or broken sleep, fatigue, irritability, strong cravings, and a flat, foggy feeling sometimes described as “not being back in my body yet.” Families often notice the person sleeping far more than usual early on, then becoming restless and anxious later in the week.

Mood is the part the clinical team watches most closely. When ketamine has been masking depression, that depression can return quickly once use stops. Staff will check in on mood and safety daily and coordinate with psychiatry. If co-occurring depression or anxiety is significant, integrated mental health treatment runs alongside the substance use work rather than after it. The National Institute of Mental Health notes that substance use disorders and mental health conditions frequently occur together and are best treated together.

A safety note that matters more than the ketamine itself: if ketamine has been used alongside daily alcohol or benzodiazepines, withdrawal from those substances can cause seizures and can be life-threatening. That withdrawal requires medical supervision. Do not stop alcohol or benzodiazepines suddenly on your own before admission. Tell admissions exactly how much and how often, so the medical team can plan a supervised taper.

The Bladder Problem Nobody Mentions on the Phone

Regular ketamine use is linked to damage to the bladder and urinary tract, sometimes called ketamine-associated uropathy or ketamine cystitis. Symptoms include needing to urinate very often, urgency, pain when the bladder fills or empties, and blood in the urine. Many people have lived with these symptoms for months and assume they are a recurring urinary tract infection that antibiotics never quite clear.

Stopping ketamine is the most important step, and some people see improvement after they stop, but severe or long-standing damage may need a urologist. A residential medical team can order a urine test, track symptoms, and arrange a referral. Visible blood in the urine, inability to urinate, fever, or severe pain needs prompt medical evaluation, not a wait-and-see approach.

If Your Ketamine Is Prescribed

A legitimate prescription does not disqualify anyone from treatment, and it does not have to be hidden. What admissions needs is the full picture: who prescribes it, the dose, the form, how often it is taken, and whether actual use matches the prescription. If it does match, the medical team will usually contact the prescriber, with your written consent, to decide together whether to pause, continue, or replace it with a different depression treatment during the stay. If use has gone beyond the prescription, say so plainly. It changes the treatment plan, and it is far better for the team to know on day one than to find out on day five.

Do not stop a prescribed depression treatment abruptly before admission without talking to the prescriber first, because mood can drop quickly.

What to Tell Admissions: A Checklist You Can Use Today

Before you or your loved one calls, write these down. It takes about ten minutes and makes the intake assessment much more accurate.

  1. Form and route: powder (snorted), liquid, lozenge, injection, or prescribed nasal or clinic treatment.
  2. Amount and frequency: a typical day or weekend, and the date and time of last use.
  3. Everything else used with it: alcohol, benzodiazepines, opioids, stimulants, cannabis, with amounts for each.
  4. Bladder symptoms: how many times a day you urinate, any pain, and any blood. If you can, keep a simple tally for the next 24 hours.
  5. Mental health history: diagnoses, current medications, and any past suicide attempts or recent thoughts of suicide.
  6. Prescriber details: name, clinic, and phone number if ketamine or esketamine is prescribed.
  7. Insurance card: front and back. You can start a check through our insurance verification page.

Then ask admissions this one question directly: “How will your medical team monitor mood and bladder symptoms in the first week, and who coordinates with my prescriber?” A program that has thought about ketamine will have a specific answer.

For Families: What You Can Do Right Now

Families often see the bathroom trips, the long periods of staring or seeming disconnected, and the mood crashes before the person admits there is a problem. You do not need to prove anything to start a conversation with admissions. Write down what you have observed and when, and call. If the person is unsafe, unresponsive, or talking about suicide, call 911 or the 988 Suicide & Crisis Lifeline by calling or texting 988. For free, confidential treatment referrals at any hour, the SAMHSA National Helpline is available, and the National Institute on Drug Abuse maintains research-based information on substances and treatment.

Getting Started in Northern California

Ketamine use is treatable, and recovery does not depend on a medication that does not exist. It depends on a careful first week, honest information at intake, and treatment that addresses whatever the ketamine was covering up. Our admissions team can walk you through the assessment, insurance, and next steps. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. If you or someone you know is in crisis, call or text 988 or call 911.

Bg1 — Bodhi Addiction Treatment & Wellness

Many people who call us about alcohol or drug treatment are also carrying a second problem they have not mentioned yet: gambling. It usually surfaces late in the admissions call, or in the first week of residential care, when someone finally says how much money is gone, which accounts are overdrawn, or why a family member stopped trusting them with a debit card. This guide explains how gambling problems are screened for during residential treatment, how they are diagnosed, what practical money safeguards help in the first weeks, and exactly what to tell admissions before you arrive.

Gambling Disorder Sits in the Same Diagnostic Chapter as Substance Use

Gambling disorder is the only behavioral addiction listed alongside substance use disorders in the DSM-5, the diagnostic manual clinicians use. A clinician diagnoses it when a person shows at least four of nine specific criteria within a 12-month period, such as repeatedly chasing losses, lying to conceal gambling, or relying on other people to cover gambling debts. In California, free and confidential help for gambling problems is available around the clock by calling 1-800-GAMBLER, and the condition can be assessed and addressed during residential treatment for alcohol or drug use.

The nine criteria cover needing to gamble with larger amounts to get the same excitement, restlessness or irritability when trying to cut back, repeated unsuccessful attempts to stop, frequent preoccupation with gambling, gambling when distressed, returning to win back losses, lying about the extent of gambling, putting a relationship, job, or educational opportunity at risk, and relying on others for money to relieve a desperate financial situation. The diagnosis is made by a clinician in an assessment, not by a checklist at home. What matters for treatment planning is that the clinical team knows to ask.

Why Gambling and Substance Use So Often Show Up Together

Research bodies such as the National Institute of Mental Health describe co-occurring conditions as common rather than exceptional, and that pattern holds for gambling. Clinicians generally point to several overlapping drivers:

  • Shared reward pathways: Both gambling and substance use act on the brain’s reward and motivation systems, so a person primed by one can be more responsive to the other.
  • Lowered inhibition: Alcohol and stimulants make larger, faster, riskier bets more likely, and many people describe their worst losses happening while intoxicated.
  • Chasing in both directions: Losses create stress, stress drives use, and use drives more gambling to “fix” the losses.
  • Money as a trigger: A paycheck, a refund, or a cash gift can trigger both cravings at once, which is why money handling becomes part of the recovery plan.
  • Substitution in early recovery: When drinking or drug use stops, some people find gambling fills the same space, which is why clinicians watch for it after a substance is removed.

What We See in Practice During the First Week

Writing from years of admissions and case management work, the pattern I see most often is not a person who arrives saying “I have a gambling problem.” It is a person who arrives in a financial emergency they have not fully explained. Week one is when the phone calls from creditors start, when a spouse discovers a second credit card, or when someone asks staff whether they can “just check one account.” The gambling was often hidden even from the person’s own sense of the problem, because the alcohol or drug use seemed like the bigger issue.

An inconvenient operational truth: many standard substance use intake forms ask little or nothing about gambling. Some programs use a brief gambling screen at assessment and some do not. If you do not raise it, it can go unaddressed for an entire stay. Families also tend to notice it first. They see missing money, new loans, sports betting apps, online casino or sweepstakes-style sites, or a person who is unusually tense around game schedules.

How Residential Treatment Addresses Both

A good residential program treats gambling as part of the same clinical picture rather than a side issue. The level of care itself is set by the substance use and medical needs, using frameworks such as the ASAM Criteria. Within that stay, gambling can be addressed through:

  • A clinical assessment that asks directly about betting, debts, and how gambling and use interact.
  • Cognitive behavioral approaches that target the thinking errors common in gambling, such as the belief that a win is “due.”
  • Relapse prevention planning that treats payday, sports seasons, and idle phone time as specific risk points.
  • Family sessions that address trust, financial transparency, and who holds which accounts after discharge.
  • Discharge referrals to gambling-specific outpatient care and peer support, alongside substance use aftercare.

Withdrawal still comes first. If the person is drinking heavily or taking benzodiazepines daily, stopping can cause seizures, and withdrawal from either must be medically supervised. No one should stop alcohol or benzodiazepines abruptly on their own to “get ready” for treatment. You can learn more about how our residential treatment program sequences detox, stabilization, and therapy.

What to Tell Admissions Before You Arrive

Here is something you can do today. Before your admissions call, write down three things on one sheet of paper:

  1. A rough total of gambling-related debt: include credit cards, payday or online loans, and money borrowed from family or friends. An estimate is fine.
  2. Any payment due dates in the next 30 days: so the team can help you plan for them instead of being blindsided mid-stay.
  3. Who currently has access to your accounts and cards: and who you would trust to hold them while you are in treatment.

Then say plainly on the call: “I also have a problem with gambling,” and ask, “How does your program assess and treat gambling alongside substance use?” Listen for a specific answer, such as a named screening tool, a clinician who works with gambling, or a family session on finances. A vague answer is useful information too. You can reach our admissions team at (877) 328-1968, and it helps to verify your insurance ahead of the call so the conversation can focus on care.

Practical Money Safeguards for the First Weeks

These steps are commonly recommended and can be set up before or during a stay, ideally with a trusted family member:

  • Ask your bank or card issuer whether it offers a gambling transaction block. Many do, and it can often be turned on in an app or by phone.
  • Give a trusted person temporary control of cards and access to account statements.
  • Delete betting and casino apps, and consider device-level blocking software.
  • Pause any automatic transfers into betting or casino accounts.
  • Avoid taking on new loans or consolidating debt in the first weeks; financial decisions are easier once you are stable.

For families, the goal is protection, not punishment. Holding the money for a while is a recovery support, and it works best when the person in treatment agrees to it.

Safety: When Losses Become a Crisis

Large gambling losses, especially combined with alcohol or drug use, can bring on intense shame and hopelessness. If you or someone you love is thinking about suicide or is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. For confidential treatment referral information about substance use, the SAMHSA National Helpline is free and available 24 hours a day. For gambling specifically in California, call 1-800-GAMBLER.

Getting Help in Northern California

Bodhi Addiction Treatment & Wellness provides residential drug and alcohol treatment in Northern California, with assessment that looks at the whole picture, including gambling, mood, and family stress. If money problems and substance use are tangled together for you or someone you love, you do not need to sort out which came first before calling. Call (877) 328-1968 to talk through the next step.

Written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, founder of Bodhi Addiction Treatment & Wellness.

This article is for educational purposes only and is not a substitute for professional medical, psychological, legal, or financial advice. Diagnosis of gambling disorder or a substance use disorder should be made by a qualified clinician. Never stop alcohol or benzodiazepines suddenly without medical supervision. If you are in immediate danger, call 911.

IV drip on a stainless steel stand — 5-day medical detox in residential rehab

Xylazine rarely comes up by name on an admissions call. People describe “fentanyl that hits different,” a sedation that lasts longer than the high, or a sore on the shin that will not close. Families describe someone who nods off for hours and is hard to wake. Those details matter, because xylazine changes how overdose is handled, how withdrawal is planned, and whether a residential program is set up to care for the wounds it causes. This post explains what xylazine is, what it means for admission to residential treatment, and exactly what to tell the admissions team before you arrive.

What Xylazine Is, in One Paragraph

Xylazine, a veterinary sedative sold on the street as “tranq,” is not an opioid and is not reversed by naloxone. It is not approved for use in people, yet the DEA’s laboratory system reported that about 23% of the fentanyl powder and 7% of the fentanyl pills it seized in 2022 contained xylazine, according to the Centers for Disease Control and Prevention (CDC). Because xylazine almost always arrives mixed with fentanyl, the CDC still advises giving naloxone in any suspected overdose, calling 911, and giving rescue breaths, since xylazine’s sedation can continue after naloxone has worked on the opioid.

The National Institute on Drug Abuse (NIDA) notes that many people take xylazine without knowing it is in their supply. NIDA also reports that, across 20 states and the District of Columbia, the share of fentanyl-related overdose deaths with xylazine detected rose from 2.9% in January 2019 to 10.9% in June 2022. Rates vary by region, and the supply changes quickly, so a person in Northern California may have been exposed without ever seeking it out.

Why Xylazine Changes the Admission Plan

From the admissions side, xylazine exposure is less about a new diagnosis and more about four practical problems that have to be planned for before day one:

  • Overdose that naloxone only partly reverses: naloxone reverses the fentanyl, but xylazine can keep breathing, heart rate, and blood pressure dangerously low, so staff and family need to know rescue breathing and 911 still come next.
  • Wounds that appear away from injection sites: NIDA reports that xylazine-related sores often show up elsewhere on the body, and some clinicians report them in people who smoke or snort rather than inject.
  • Withdrawal that may be harder than fentanyl alone: early research cited by NIDA suggests withdrawal symptoms may be more intense with xylazine plus fentanyl, and no medical association has yet published a xylazine-specific withdrawal guideline.
  • A drug screen that will not show it: standard urine drug panels do not test for xylazine, so the clinical team often learns about exposure only from what the person or family reports.

That last point is the inconvenient operational truth. If nobody mentions xylazine or a wound during the pre-admission screening, the team may plan an ordinary opioid admission and only discover the wound during the physical exam on arrival. Some wounds can be managed in a residential setting with daily dressing changes and a medical provider’s oversight. Others need hospital or wound-clinic care first. The admissions team can only make that call in advance if they are told.

Wound Care: What Residential Programs Can and Cannot Do

According to NIDA, xylazine-related wounds range from skin infections and abscesses to open, weeping ulcers, and untreated wounds can progress to dead tissue and, in rare severe cases, amputation. NIDA notes that medical associations have not issued formal treatment guidelines, but early evidence favors keeping wounds clean and open rather than closed with stitches or grafts. Wounds can heal while a person is still using, though early data suggest healing is slower with continued xylazine exposure.

In practice, this is what to expect from a residential program that accepts someone with a xylazine-related wound:

  • A physical exam on arrival that documents each wound, its size, and any signs of infection.
  • A dressing plan, with who changes dressings and how often written down.
  • A pain plan, because these wounds hurt, and untreated pain is a common reason people leave early.
  • A clear threshold for sending the person out: fever, spreading redness, a foul smell, or a wound that is getting deeper means same-day medical evaluation, not waiting for the next scheduled visit.

If a program cannot describe that plan, ask whether medical clearance from a primary care provider, urgent care, or wound clinic is needed first. Asking that question on the phone is far better than discovering the gap at intake.

Withdrawal Planning When Xylazine Is Involved

Most people exposed to xylazine are also dependent on fentanyl, so withdrawal planning starts with opioid withdrawal management and a discussion of medications for opioid use disorder, which the Substance Abuse and Mental Health Services Administration (SAMHSA) identifies as an evidence-based part of treatment. Xylazine adds uncertainty: symptoms such as anxiety, restlessness, and irritability may be stronger or last longer, and there is currently no medication approved specifically for xylazine withdrawal, so clinicians treat the symptoms they see.

Safety note: NIDA reports that most overdose deaths involving both xylazine and fentanyl also involved other substances, including benzodiazepines and alcohol. Withdrawal from alcohol or benzodiazepines can cause seizures and can be life-threatening. If either is part of the picture, withdrawal must happen under medical supervision, and nobody should stop alcohol or benzodiazepines abruptly on their own while waiting for a bed.

This is one reason a residential treatment admission for someone with xylazine exposure usually begins with a medically monitored stabilization period rather than going straight into a full group schedule.

What to Tell Admissions: A Checklist You Can Use Today

Before the screening call, write down the answers to these questions. If you are a family member, ask your loved one for permission to share them, or have them on the call with you.

  1. What is being used, and how? List every substance, including alcohol, benzodiazepines, gabapentin, and stimulants, and whether each is injected, smoked, snorted, or swallowed.
  2. When was the last use of each? Give a date and approximate time. This sets the withdrawal timeline.
  3. Has anyone said “tranq” or noticed unusually long sedation? Mention it even if you are not sure.
  4. Are there any wounds? Note how many, where on the body, roughly how large, and whether any are red, hot, draining, or smell bad. A photo taken today can help the medical team decide whether clearance is needed first.
  5. Any recent overdoses? Say whether naloxone was used and whether it fully worked.
  6. Current prescriptions and pharmacy. Include any buprenorphine or methadone dose.

Then ask the admissions team two direct questions: “Can your medical staff manage open wounds on site, and how often are dressings changed?” and “Do you need medical clearance before admission for someone with these wounds?” You can reach our admissions team at (877) 328-1968, and it helps to verify insurance in the same call so the clinical and financial questions are settled together.

While You Wait for a Bed

The days between the first call and admission carry real risk. Keep naloxone in the home and make sure more than one person knows where it is. If someone is unresponsive or breathing slowly, give naloxone, call 911, and give rescue breaths if you are able, then stay with them; the CDC notes that xylazine’s effects can continue after naloxone. Xylazine test strips are commercially available and offered by some harm reduction programs, according to NIDA. Keep any wound clean and covered, and get it seen the same day if it shows signs of infection.

A Note From Clinical Practice

This guidance reflects the admissions and case management work of Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. The pattern that most often delays care is not the xylazine itself but the missing detail: a wound nobody mentioned, or a benzodiazepine nobody listed. Admissions teams are not looking for reasons to turn people away. They are trying to make sure the first 72 hours are medically safe. The more specific the information on the first call, the faster that plan comes together. If you are unsure whether a program is the right fit, call (877) 328-1968 and ask the questions above.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed medical provider. If someone is unresponsive, not breathing, or breathing very slowly, call 911 immediately. If you or someone you know is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

Clinician meeting with a patient during cocaine and alcohol residential detox intake at a Santa Cruz treatment center

For many veterans, the hardest part of getting into residential treatment is not deciding to go. It is figuring out which system pays, which office has to approve it, and in what order. Veterans may be eligible for VA health care, TRICARE, private insurance through an employer, Medicare, or some combination, and each one has its own rules about authorization. A family can spend a week on the phone and still not know whether a bed is covered.

This guide walks through how the coverage paths usually work for veterans seeking residential drug and alcohol treatment in Northern California, what tends to slow things down, and exactly what to have in hand before you call admissions.

The Short Version: Authorization Comes Before Admission

For a veteran using VA benefits to pay for residential treatment at a non-VA program, the VA referral and authorization generally has to be in place before admission, not after. Under the VA Community Care Program created by the MISSION Act, the VA decides whether a veteran is eligible for care outside a VA facility, issues a referral, and authorizes a specific episode of care with a specific community provider. Non-emergency care received without that authorization may not be paid. The main exception is emergency care, where the VA asks to be notified within 72 hours of the visit. If a veteran is in crisis right now, the Veterans Crisis Line is reached by dialing 988 and then pressing 1.

That paragraph is the single most useful thing to understand. In our consultation work, the delay we see most often with veterans is not clinical. It is a family finding a program, agreeing on a start date, and only then learning that the VA has not yet issued a referral, so the start date slips while paperwork catches up.

The Main Coverage Paths for Veterans

Which route applies depends on discharge status, enrollment, and whether the veteran still has military or employer coverage. The most common paths are:

  • VA residential programs: The VA runs its own Mental Health Residential Rehabilitation Treatment Programs, some of which focus on substance use disorders. Access goes through the veteran’s VA mental health or primary care team.
  • VA Community Care: When the VA cannot provide the needed care in a timely way or within a reasonable distance, or when it is in the veteran’s best medical interest, the VA may authorize care at a community provider. Since 2019 the VA has used drive-time and wait-time access standards to help decide this; those standards have been the subject of ongoing legislative debate, so confirm the current rules with your VA team rather than relying on any article, including this one.
  • TRICARE: Retirees and their families, and some reserve members, may have TRICARE. TRICARE covers substance use disorder treatment, but residential care generally requires prior authorization through the regional contractor.
  • Private insurance or Medicare: Many veterans are covered through an employer plan or Medicare. These follow their own utilization review process, and California’s mental health parity law applies to state-regulated commercial plans.

Veterans can sometimes have more than one source of coverage. When that happens, the order in which plans pay matters, and it is worth asking the program’s billing team to confirm it before admission. You can start that process through our insurance verification page.

Why Veteran Admissions Stall

These are the patterns that most often add days or weeks between “I’m ready” and a bed:

Referral sequence: The program is chosen first and the VA referral is requested second, so the admission date waits on an authorization that has not been started.

Enrollment gaps: Some veterans were never enrolled in VA health care or let it lapse, and enrollment has to be confirmed before a community care referral can be issued.

Provider network mismatch: Community care can only be authorized with a provider that participates in the VA’s community care network, so a program a family likes may not be an option under that benefit.

Unclear authorization scope: An authorization usually covers a defined episode of care. If no one asks how many days were approved and how an extension is requested, the stay can be interrupted midstream.

Withdrawal timing: A veteran who is drinking daily or using benzodiazepines cannot safely stop on their own while waiting for paperwork. Alcohol and benzodiazepine withdrawal can cause seizures and can be life-threatening, and medically supervised withdrawal management is required. That may mean detox needs its own authorization ahead of residential care.

What Veterans and Families Tend to Experience in the First Week

Veterans often arrive at residential treatment with a well-trained habit of downplaying symptoms and pushing through. In week one, that can look like insisting sleep is fine when it is not, or describing drinking in the same flat terms used for any other duty report. Many are also managing chronic pain, a traumatic brain injury history, or post-traumatic stress, and these conditions frequently overlap with substance use, as both the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism note in their public education materials.

Families often notice that structure helps. A predictable schedule, clear expectations, and a clinical team that explains the reason behind each rule tend to land well with people who spent years in a system built on those things. What usually helps less is being treated as a category. Good residential care plans around the specific person: their sleep, pain, medications, family situation, and what they want the next year to look like. Our residential treatment page describes how that daily structure works.

Trauma work, when it is part of the plan, usually follows a sequence. Early stabilization comes first, and deeper trauma processing is typically introduced once sleep, withdrawal, and safety are steady.

What to Do Before You Call Admissions

This is a checklist you can work through today. Having these answers ready usually shortens the admissions process considerably.

  1. Confirm enrollment status. Find out whether the veteran is currently enrolled in VA health care. If unsure, contact the enrollment office at the nearest VA medical center.
  2. Find the VA care team. Write down the name of the veteran’s VA primary care provider or mental health clinician. That team is usually who initiates a community care referral.
  3. Ask the VA these exact questions: “Is residential substance use treatment available at a VA program, and what is the wait? If not, will you issue a community care referral? Which community providers near us are in network? How many days will the authorization cover, and how is an extension requested?”
  4. Get the referral details in writing. Ask for the referral or authorization number and the dates it covers.
  5. Check other coverage. List any TRICARE, Medicare, or employer insurance, with member ID numbers, so the program can determine which plan pays first.
  6. Be honest about current use. Tell admissions how much and how often the veteran is drinking or using, and the time of last use. This decides whether medically supervised detox has to come first.

Once you have those answers, call our admissions team at (877) 328-1968. If you would rather have someone help sort through the coverage questions with you, a treatment consultant can walk through the options.

Where the Standards Come From

Residential placement decisions are generally guided by the ASAM Criteria from the American Society of Addiction Medicine, which look at withdrawal risk, medical and psychiatric needs, readiness, relapse risk, and the recovery environment. Payers, including VA and TRICARE reviewers, typically want to see that the requested level of care matches that kind of assessment. SAMHSA’s 988 resources describe how the 988 Suicide and Crisis Lifeline works, including the Veterans Crisis Line option.

If Someone Is in Danger Right Now

If a veteran is thinking about suicide or is in immediate danger, dial 988 and press 1 for the Veterans Crisis Line, or call 911. Do not wait for an authorization to sort out an emergency. Emergency care comes first, and the coverage questions can be handled afterward.

For non-emergency questions about residential treatment, coverage, or timing, our team is available at (877) 328-1968.

This article is for educational purposes only and is not medical, legal, or financial advice. VA, TRICARE, and insurance rules change and vary by individual circumstance; confirm eligibility and authorization directly with the VA, your plan, and the treatment program. Do not stop alcohol or benzodiazepines abruptly without medical supervision.